Complement1 Secures $16M Seed Round to Revolutionize Cancer Survivorship with Personalized Lifestyle Interventions

Complement1 is thrilled to announce a major milestone in its journey to revolutionize cancer care—a funding round that successfully raised $16,000,000. With a clear, impactful mission to transform cancer outcomes through evidence-based lifestyle interventions that truly stick, Complement1 is uniquely positioned at the intersection of innovative care and compassionate support for cancer survivors. This latest capital infusion will not only accelerate the company’s growth but also expand its pioneering daily 1:1 lifestyle modification program, the first of its kind to receive clinical validation. Designed meticulously with cancer survivors in mind, this program harnesses personalized 1:1 live coaching to deliver targeted interventions in physical activity, nutrition, breathwork, and trauma healing, each tailored to the specific cancer type, treatment stage, and individual physical ability. Backed by leading oncologists and robust clinical evidence, Complement1’s approach is redefining how post-treatment care can improve quality of life, reduce recurrence rates, and extend survival. The funds raised will be strategically invested in scaling operations, broadening access to the program, and refining technology to better serve the needs of diverse cancer survivor populations. Additionally, this capital will support further research and development initiatives designed to strengthen the evidence base behind lifestyle approaches and enhance the personalization of interventions, ensuring every participant receives care that is as unique as their journey. This funding milestone marks a significant step forward in Complement1’s commitment to empowering cancer survivors, and it underscores the growing recognition of the importance of holistic, lifestyle-based strategies in modern cancer care.